High VEGF Level is Produced by Human Umbilical Cord- Mesenchymal Stem Cells (hUC-MSCs) in Amino Acid-Rich Medium and under Hypoxia Condition by Sidharta, Veronika Maria et al.
 222
VEGF Production by Hypoxic hUC-MSC in AA-rich Medium (Sidharta VM, et al.)Indones  Biomed J.  2018; 10(3): 222-30DOI: 10.18585/inabj.v10i3.457 R E S E A R C H  A R T I C L E
High VEGF Level is Produced by Human Umbilical Cord-
Mesenchymal Stem Cells (hUC-MSCs) in Amino Acid-Rich Medium and 
Under Hypoxia Condition 
Veronika Maria Sidharta1,2, Elizabeth Henny Herningtyas3,, Christine Ayu Lagonda4, 
Dilafitria Fauza4, Yuyus Kusnadi4, Rina Susilowati5, Ginus Partadiredja6  
1Doctoral Program, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Farmako Sekip Utara, Yogyakarta, Indonesia
2Histology Department, School of Medicine and Health Science, Atma Jaya Catholic University of Indonesia, Jl. Pluit Raya No. 2, Jakarta, Indonesia
3Clinical Pathology and Laboratory Medicine Department, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, 
Jl. Farmako Sekip Utara, Yogyakarta, Indonesia 
4Stem Cell and Cancer Institute, Jl. A. Yani No. 2, Jakarta, Indonesia
5Histology and Biology Cell Department, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Farmako Sekip Utara, 
Yogyakarta, Indonesia
6Physiology Department, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Farmako, Sekip Utara, Yogyakarta, Indonesia 
Corresponding author. E-mail: ehennyh@ugm.ac.id
Received date: Apr 23, 2018; Revised: Jun 18, 2018; Accepted: Jun 19, 2018
BACKGROUND: Secretome production by stem cells depends on their culture conditions such as oxygen concentration and the composition of the 
culture media. In this study, we investigated the secretion 
of neurotrophic growth factors of human umbilical cord 
mesenchymal stem cells (hUC-MSCs) in amino acid-rich 
culture medium and under hypoxic condition. 
METHODS: hUC-MSCs were cultured in normoxic and 
various hypoxic (1%, 5%, 10%) conditions in an amino 
acid-rich culture medium. The end-point parameters (cell 
proliferation and survival, cell morphology and growth 
factor secretion) were measured at 3 time-points (48 hours, 
72 hours and 96 hours). ELISA-based methods were used 
for neurotrophic factors detection, including neurotrophic 
growth factor (NGF), vascular endothelial factor (VEGF), 
and brain-derived neurotrophic factor (BDNF). 
RESULTS: NGF secretion was not detectable at any time 
points both in normoxia and hypoxia. BDNF secretion 
under normoxia was induced at 48 h time point and reached 
the highest level at an average of 181.9±13.01 pg/mL at 
96 hours, whereas hypoxia exposure to hUC-MSCs only 
induced the BDNF secretion at low level. VEGF secretion 
was barely detectable in normoxic condition. However, 
VEGF secretion reached the highest level at an average of 
7707.55±2110.85 pg/mL in 5% hypoxia at 96 hours.
CONCLUSION: Combination of amino acid-rich culture 
medium and hypoxia condition dramatically induced high 
VEGF secretion by hUC-MSCs, especially at 5% hypoxia, 
induced mild BDNF secretion and had no effect toward 
NGF secretion.  
KEywORDS: human umbilical cord mesenchymal stem 
cells, neurotrophic growth factor, amino acid-rich, hypoxia
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Abstract
Introduction
Mesenchymal stem cells (MSCs) were first identified from 
bone marrow cells in 1966 by Friedenstein.(1) Recently, 
MSCs have been isolated from almost every tissue in the 
body,  including  human  umbilical  cord  MSCs  (hUC-
MSCs).(2,3) The International Society for Cellular Therapy 
(ISCT) defines that MSCs are characterized by the expression 
of the surface markers cluster of differentiation (CD)73, 
CD90 and CD105, and are negative for the expression of 
CD11b, CD14, CD19, CD79a, CD34, CD45 and human 
leukocyte antigen (HLA)-DR. Moreover, MSCs also have 
the ability to differentiate into osteoblasts, adipocytes, and 
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chondroblasts in vitro.(4)  Since  this  discovery,  stem 
cell  therapy  has  become  a  promising strategy to treat 
many degenerative problems, including neurodegenerative 
disorders.(5-7) Compared to MSCs from other sources, 
hUC-MSCs, especially from Wharton’s jelly (WJ), have 
many advantages such as accesibility, painless procedures 
for donors, no ethical controversy, and lower risk of 
contamination.(8)
 Three main functions of stem cell therapy are 
replacement of tissue via multipotent differentiation, 
immunomodulatory and anti-inflammatory effects, and 
secretion of molecules (secretome) that instigate or assist in 
tissue repair.(9)  
 However, some limitations are found in this strategy, 
including the cells’ short lifespan, senescence-induced 
genetic instability, and possible malignant transformation of 
stem cells.(10) It is now commonly accepted that the potency 
of stem cell therapy is related mainly to the secretome, the 
complex set of molecules secreted by the stem cells or shed 
from their cell surfaces, that support cell survival and create 
a suitable environment for regeneration by endogenous 
cells.(11,12)
 Secretome from hUC-MSCs contains factors related to 
neuroprotection, neurogenesis, and angiogenesis (13) which 
is beneficial in neuroregenerative therapy. The secretome’s 
composition depends on stem cell’s culture conditions. 
Finding the optimum method to enhance the secretome 
composition is believed to improve stem cells’ therapeutic 
potential. Previous studies showed that secretome production 
are influenced by incubation duration within low oxygen 
tension, and culture media which stimulates secretome 
release.(11,14-16) Different composition of media will 
affect the growth rate, differentiation potential and surface 
marker expression of mesenchymal stem cells.(17) Lower 
glucose concentrations will lead to a decreased apoptosis, 
decreased senescence, and increased proliferation rate of 
MSC.(15,16) 
 Various compositions of culture media are available, 
which includes high glucose and high minerals culture 
medium, for instance, Dulbecco’s Modified Eagle 
Medium: Nutrient Mixture (DMEM)-F12 or high glucose 
and moderate amino acid content provided in Minimum 
Essential Media (MEM). A comparison between different 
basal culture mediua supplemented with 10% fetal bovine 
serum (FBS) revealed that DMEM-KO (knockout) and 
DMEM-F12, compared with DMEM-LG (low glucose) and 
DMEM-HG (high glucose), are the most optimal culture 
medium for WJ-MSCs.(18) Both Minimum Essential 
Methods
Isolation and Culture of hUC-MSCs
hUC-MSCs stock cells were obtained from Stem Cell and 
Cancer Institute (SCI), Jakarta, Indonesia. These cells were 
originally isolated from human umbilical cords which were 
aseptically collected during caesarian sections. The vessels 
were manually removed from umbilical cord segments and 
the tissue was dissected into 1 mm x 1 mm pieces. The 
tissue pieces were planted in a culture dish for 14 days 
until mesenchymal stem cells were diffused out from the 
tissue and attached to the vessel. They were then passaged 
continuously from P0 until P6 using TrypLe (Gibco, NY, 
USA) when they attained 75-85% confluence. The cells 
were cultured in MEM Alpha (Gibco) that contained low 
glucose and rich non-essential amino acids, supplemented 
with 10% FBS (Gibco), 1% penicillin-streptomycin (Sigma, 
Missouri, USA) and incubated at 37oC with 5% CO2 and 
95% humidity.
Characterization of hUC-MSC by Immunophenotyping 
Cell surface marker analysis for hUC-MSCs was conducted 
when the culture had reached 6th passage to characterize 
and determine positivity percentage of hUC-MSCs in 
isolated samples, using monoclonal antibodies conjugated 
with phycoerythrin (PE) fluorescent dye. Flow cytometry 
analysis using BD FACSCalibur (BD Bioscience, New 
Jersey, USA) was performed to analyze these cell-surface 
epitopes; CD73, CD90, CD105 (as positive markers of 
MSCs), CD14, and CD45 (as negative markers) (R&D 
Systems, Minnesota, USA). For each sample, a minimum of 
10,000 events were acquired and result were analyzed with 
CellQuestPro software (BD Biosciences). 
Medium Eagle-Alpha modification (MEM Alpha) and 
DMEM-F12 contain high amino acid, however MEM 
Alpha has much higher concentrations of glycine, alanine, 
asparagine, aspartic acid, cysteine hydrochloride, glutamic 
acid and proline. In addition, MEM Alpha has lower glucose 
concentration compared to DMEM-F12 (Supplemental 
Data). There is limited information about the ability of 
hUC-MSCs to release secretome in amino acid-rich culture 
medium under hypoxic conditions, in this case is MEM 
Alpha. Thus in this study, we investigated the effects of 
various hypoxic conditions on the secretion of neurotrophic 
growth factors in an amino acid-rich culture medium, MEM 
Alpha.
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Results
Figure 1. Characterization of hUC-MSCs. The phenotypic 
markers CD73, CD90, CD105, CD14, dan CD45 were assessed 
by flow cytometry.  Positive populations of surface markers CD73, 
CD90, and CD105, also the lack of surface markers CD14 and 
CD45, confirmed that these cells are MSCs.
in vitro Hypoxia
hUC-MSCs were cultured up to 6th passage to be used for 
secretome production. Cells were seeded in T-25 flasks 
at a density of 7000 cells/cm2 in the culture medium until 
reaching 80% confluency. After the desired confluency 
was achieved, serum content in the culture medium was 
deprived by washing the cells with Phosphate Buffered 
Saline (PBS, Lonza, Basel, Switzerland) prior to medium 
changing into serum-free medium (MEM Alpha) without 
phenol red. The cells were then cultured under following 
conditions: normoxia (21% O2) or hypoxia (1, 5 and 10% 
O2) conditions, n=3. Secretome collection points were 
conducted at 48 hours, 72 hours, and 96 hours. To mimic 
hypoxia condition, the cells were incubated in a tri-gas 
incubator (Heracell Vios 160i, Thermo Scientific Heraeus, 
Germany) with humidified gas mixtures of O2, CO2, and N2. 
Collected secretome was then aliquoted into an appropriate 
volume and stored at -80oC until further analysis.  
Survival and Proliferation of hUC-MSC under Hypoxia
At the end of the cultivation, the cells were washed with 
PBS, trypsinized and incubated at 37oC in a flask for 
approximately 7 minutes. The flask was gently shaked to 
physically detached the cells and collected cells were further 
centrifuged for 4 minutes at 160 g. The pelleted cells were 
then resuspended in 1 mL of basal medium to be further 
counted using a haemocytometer (Brand GMBH + CO KG, 
Wertheim, Germany).
Cell Morphological Changing Observation 
Photomicrographs of hUC-MSCs from all hypoxia groups at 
all time points were taken from 5 designated locations, from 
each corner (4 locations) and in the middle (1 location) of 
the flask. Comparisons of cells from these photomicrographs 
were performed by 3 different examiners.  
Growth Factor Measurement by ELISA
The collected secretome was analyzed by enzyme-linked 
immunosorbent assay (ELISA) using vascular endothelial 
factor (VEGF), neurotrophic growth factor (NGF), and 
brain-derived neurotrophic factor (BDNF) Immunoassays 
(R&D Systems) according to the manufacturers' protocol. 
All measurements were done in 3 replications together with 
step-wise dilution standard. The absorbance was read using 
microplate reader (BioRad, California, USA) at 450 nm with 
the correction at 540 nm. ELISA results for neurotrophic 
growth factors were analyzed in 4 parameter logistics 
regression tests using software analyzer (MyAssays). 
Statistical Analysis
The data are presented as mean±standard deviation. 
After all of the data passed the normality test, statistical 
comparisons were performed using one-way analysis 
of variance (ANOVA) as appropriate according to data 
distribution (n=3). Significant differences were further 
investigated using Tukey's HSD multiple comparison test. 










Isolated hUC-MSCs Represented MSCs Characteristics
The isolated cells showed MSCs positive markers as follows: 
CD73 (99.26%), CD90 (99.52%), CD105 (99.47%), and 
were lack of CD14 (0.00%) and CD45 (0.26%) (Figure 1). 
The isolated cells highly expressed positive MSCs surface 
markers, therefore indicating that those cells were MSCs as 
defined by ISCT.
hUC-MSCs Proliferation was Found Higher in Hypoxia 
Compared to Normoxia
The hUC-MSCs showed an increase of cell number from the 
basal level (0 hour) after 48 hours in normoxia or hypoxia 
conditions with different proliferation rates (Figure 2a). 
Cells in normoxia condition showed 2.86-fold increase of 
proliferation rate, while cells in 10%, 5% and 1% hypoxia 
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Figure 2. hUC-MSCs counts (a) and cells increment (b) from normoxic/hypoxic conditions at 3 time points. Significant difference 
with normoxia is represented with * (p<0.05).
showed increases of 4.4 fold, 5.06 fold and 2.14 fold, 
respectively, of proliferation rate (Figure 2b). 
 After 72 hours incubation, almost all cell groups 
showed a reduction in cell number compared to 48 hours 
incubation at a range of 16.6%-49.4%, except for cells in 
1% hypoxia condition that showed slight increment of cell 
number (14%). The reduction of cell number was higher at 
96 hours incubation than that at 48 hours incubation in all 
cell groups at a range of 24%-76.3%. The most optimum 
proliferation rate was found at 48 hours incubation in 5% 
hypoxia condition (Figure 2a, 2b). This was then followed 
by the reduction of cell number in longer incubations.
 
Hypoxia did Not Gave Significantly Different 
Morphology to hUC-MSCs
The  morphology  of  cells  cultured  under  normoxia 
conditions showed no significant difference on each time 
points (Figure 3a-3c).  After the exposure of 10% and 5% 
hypoxia conditions for 48 hours and 72 hours, all cells 
showed  reduction  in  size  and  became  slimmer  in 
appearance, especially at 96 hours (Figure 3d-3i). 
 Cells cultured under 1% hypoxia conditions at 72 
hours and 96 hours showed tendency to form clump (Figure 
3j-3l, circled) and more of dead cells were found.  
Hypoxia Induced Significant VEGF Secretion, Mild 
BDNF Secretion and No NGF Secretion. 
The neurotrophic factors NGF, BDNF, and VEGF released 
by hUC-MSCs under normoxic and hypoxic conditions 
were quantified by ELISA. There were no detectable NGF 
secretion at any time point cultured in both normoxia and 
hypoxia. 
 In normoxia group, the BDNF secretion was induced 
at 48 hours time point and reached the highest level at an 
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Figure 3. Photomicrograph of hUC-MSCs from normoxic/hypoxic conditions and 3 time points. a. Normoxic, 48 h; b. Normoxic, 72 
h; c. Normoxic, 96 h; d. 10% hypoxic, 48 h; e. 10% hypoxic, 72 h; f. 10% hypoxic, 96 h;  g. 5% hypoxic, 48 h; h. 5% hypoxic, 72 h; i. 5% 
hypoxic, 96 h; j. 1% hypoxic, 48 h; k. 1% hypoxic, 72 h; l. 1% hypoxic, 96 h.  No particular issues or differences regarding cell morphology 
between hUC-MSCs cultured in normoxic and hypoxic conditions, in any culture durations.  However, hUC-MSCs cultured under 1% 
hypoxic grew bigger in size with the tendency to form clump (circled). bar: 100 µm.
average of 181.9±13.01 pg/mL at 96 hours (Figure 4a). 
This secretion increment was 1.7 fold higher compared to 
48 hours time point. The hypoxia exposure from 1-10% 
oxygen levels induced the BDNF secretion at a lower level 
compared to the normoxia group at the studied time points. 
This finding indicated that normoxia had better ability to 
induce BDNF compared to hypoxia.
In contrast to the BDNF secretion, VEGF secretion was 
barely detectable in normoxia.  However, in 5% hypoxia at 
96 hours, the VEGF secretion reached the highest level at an 
average of 7707.55±2110.85 pg/mL (p<0.05; Fig. 4b). This 
result indicated that VEGF was very sensitive to oxygen 
tension changes and long-time exposure of low oxygen 
level, especially at 5% hypoxia.
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Figure 4. Comparison of neurotrophic growth factors measured in the medium under normoxic/hypoxic conditions and collected 
after 3 time points. The growth factors were analyzed by ELISA for NGF (not shown), BDNF, and VEGF. Significant difference with 
normoxia is represented with * (p < 0.05).
Taken together, when we compared BDNF concentration 
to VEGF concentration in a ratio (Table 1), a gradual 
changing along with culture duration was found. The ratio 
was gradually increasing in 5% and 10% hypoxia, however 
the ratio in 1% hypoxia showed decreased value in longer 
culture duration. These results suggested that in hypoxic 
condition, the increment in VEGF concentration was much 
higher than BDNF concentration that could change BDNF 
to VEGF ratio dramatically.
Discussion
In this study, we have explored the potency of hUC-MSCs 
to release neurotrophic growth factors in amino acid-rich 
medium and under various hypoxic conditions. We chose 
commercial medium like MEM Alpha that contained higher 
concentration of non-essential amino acid such as alanine, 
aspartic acid, asparagine, and glutamic acid, also higher 
concentration of conditionally non-essential amino acid 
such as glycine, cysteine and proline (Supplemental Data) 
compared to DMEM F12 that had been commonly used 
in previous studies.(14,19-21) FBS was avoided in these 
experiments since the presence of cytokines contained in 
FBS would complicate the analysis.
 A study by Majumdar, et al., reported that human 
umbilical cord  WJ-MSCs which were cultured in DMEM 
F12 under 2% hypoxia condition showed a gradual decrease 
of cell number from 24 hours until 96 hours incubation with 
the lowest cell percentage at 24% in 96 hours incubation.
(14) This result was different from ours that found an 
increase of cell number in hypoxia condition at 48 hours 
incubation followed was slightly different from ours that 
found a constant number of harvested cells when incubated 
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Time Points Oxygen Tension BDNF : VEGF Ratio
21% 1 : 0.03
10% 1 : 1.21
5% 1 : 40.17
1% 1 : 51.24
21% 1 : 0
10% 1 : 7.23
5% 1 : 41.11
1% 1 : 74.64
21% 1 : 0
10% 1 : 8.38
5% 1 : 64.02




for 48 hours and 72 hours but decrease significantly in 96 
hours time point. Similar to Majumdar’s study, we might 
conclude that prolong incubation for 96 hours resulted in 
apoptosis fate.(14) The 1% hypoxic condition that we 
used in this experiment could be a lethal condition for the 
cells since it was not the MSCs niche because MSCs need 
physiologic O2 level which was approximately at 2%-8% 
O2 level as described by Mohyeldin, et al., to be able to give 
molecular and cellular responses.(22)   
 Drela, et al., found that the morphology of the WJ-
MSCs cultured in human MSC growth medium under 5% 
hypoxia  for  2-4  weeks  is  relatively  smaller  in  size 
and round,  with  a  tendency  to  lay  one  on  the  top  of 
another at the center of proliferation and forming colonies 
(colony-forming unit fibroblasts).(23) In contrast, the 
cells grew under normoxia rarely formed similar centers 
of proliferation. These findings are similar with ours, 
considering that the culture time in our study were only 
up to 96 hours, but we only found clumped cells under 1% 
hypoxia at 72 hours and 96 hours time points. 
 In our study, BDNF level had higher secretion under 
normoxia than hypoxia, this is similar to previous study.(14) 
This result suggests that the BDNF expression and secretion 
does not rely on the oxygen tension level and a normal 
oxygen level gives rise to the optimum BDNF secretion. 
Under considerably the same conditions with other study 
(14), despite higher release of VEGF, the BDNF release in 
our study was lower. This suggest that BDNF might need 
different composition of nutrients in the culture medium. 
 In contrast, NGF level did not have any changes at all, 
both in normoxia and hypoxia at any time points. This result 
Table 1. The BDNF:VEGF ratio at 3 time points 
and various oxygen tensions.
suggested that NGF was not secreted by MSCs despite 
oxygen tension changing. We assume that NGF release is 
tissue-related.
 We found that hypoxia condition, especially at 5% 
hypoxia, significantly increased VEGF secretion with the 
highest at 72 hours time point. This finding is similar with 
previous report (24), but different with other (14) that the 
release of VEGF was significantly higher under hypoxia 
conditions up until 48 hours time point then decreased 
considerably by 72 hours of incubation. On the contrary, 
another study (12) barely detected VEGF in secretome 
of human umbilical cord perivascular cells (hUC-PVCs) 
cultured under normoxia (except at 72 hours). This 
difference might be related to the different composition of 
the culture medium or source of cell used in our studies.
 VEGF release in our study was significantly higher 
under hypoxia condition than normoxia. This might be 
due to the upregulation of hypoxia inducible factor (HIF)-
1 alpha in hypoxia which will increase the expression of 
VEGF.(25) The release of VEGF was also higher compared 
with other study under relatively same conditions in our 
study (14), at approximately 7 fold concentration of their 
study. Such high release of VEGF was a surprising result 
since the hUC-MSC was under stress condition because of 
the limited oxygen tension which at a certain point might 
blunt the cells’ ability to produce growth factors and to 
survive. We assume this might be related to the different 
composition of culture medium used.
 We assume that despite of hypoxic mechanism 
that induced VEGF secretion, there are other additional 
mechanisms that work synergistically with the hypoxic 
mechanism to give high increasing fold of VEGF release. 
Since the concentrations of several amino acids content 
in our study were higher than previous studies, we are 
considering that amino acids might play an important role 
as additional mechanisms to induce VEGF secretion. 
 Hypoxia condition is known to induce VEGF secretion 
via HIF-1 alpha signaling pathway (25) and a recent study 
by Lee, et al., revealed that there is a novel mechanism of 
cell proliferation and migration via HIF-1 alpha/fatty acid 
synthase (FASN) axis, which activates the mammalian 
target of rapamycin complex 1 (mTORC1) (26). 
 mTORC1 is a complex composed of the protein kinase 
mTOR, regulator-associated protein of mTOR (Raptor), 
mammalian lethal with SEC13 protein 8 (mLST8; GβL), 
proline-rich Akt substrate 40 kDa (PRAS40), and DEP 
domain containing mTOR-interacting protein (Deptor), 
Tti1, and Tel2 (27,28). This mTORC1 complex is activated 
by several metabolic resources such as amino acids, energy 
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sources, growth factors, cytokines, and hormones and 
hypoxia condition.(26,27)
 Amino acids take part in mTORC1 activation by 
priming and activating, which are two discrete and separable 
steps.(29) The group of priming amino acids includes 
L-asparagine, L-glutamine, L-threonine, L-arginine, 
L-glycine, L-proline, L-serine, L-alanine, and L-glutamic 
acid.  The group of activating amino acids includes 
L-leucine, L-methionine, L-isoleucine, and L-valine. 
MEM alpha contains higher concentration of L-asparagine, 
L-glycine, L-proline, L-alanine and L-glutamic acid that 
all belong to priming amino acids for mTORC1 activation. 
Although activating amino acids contents in MEM alpha are 
present in moderate concentrations however such amounts 
might be functional to activate mTORC1.  
 The limitations of our study are we did not explore 
the gene regulation mechanisms in this study, so we do 
not know the exact mechanisms of VEGF induction in our 
study, thus further investigation is needed to clarify the 
exact mechanism of high secretion of VEGF found in our 
study. 
 Furthermore, VEGFs are a family of secreted 
polypeptides with a highly conserved receptor-binding 
cystine-knot structure similar to platelet-derived growth 
factors.(30) There are five members of VEGF family 
in mammals: VEGF-A, placenta growth factor (PGF), 
VEGF-B, VEGF-C, and VEGF-D. VEGF-A is the most 
abundant and the prototypical member of this family. 
Studies on VEGF-A have given most of the information 
about localization and expression of all of the VEGFs.(30) 
Hypoxia upregulates VEGF-A gene expression (25,30), 
but not VEGF-B and VEGF-C (31). About VEGF-D, little 
is known whether hypoxia or other factors upregulate it 
(31) but some reports found that VEGF-D expression is 
upregulated in tumors (32,33). We did not measure each 
of the VEGF family members secreted by hUC-MSCs 
since our ELISA kit was only able to measure total VEGF. 
Further investigation using a more specific ELISA kit for 
each VEGF family members secreted by hUC-MSCs can 
give more information about VEGF family members most 
affected by exposure in our study.
Conclusion
In conclusion, a combination of amino acid-rich medium 
and hypoxia condition induced dramatically high VEGF 
secretion by hUC-MSCs. However, such combination did 
not have any significant effect toward the secretion of NGF 
and BDNF.
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